Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-11-13FDA Approved: CISPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for cisplatin filed by Fresenius Kabi USA, LLC. This action confirms the continued approval of cispl…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer [NA]
A completed clinical trial evaluated microsphere-delivered cytokines to boost tumor lymphocyte response in patients with head and neck cance…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery [Phase 2]
A Phase 2 trial evaluated pegylated interferon alfa-2b in patients with surgically resectable stage II–IV head and neck cancer, and the stud…
-
CLINICAL_TRIALS research · 2012-10-30Clinical Trial Update: Pain: Screen and Treat [Phase 3]
Phase 3 trial update for Pain: Screen and Treat in head and neck cancer, sponsored by Royal Marsden NHS Foundation Trust; current status is …
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus-positive nasopharyngeal carcinoma; study status is comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx [Phase 3]
Phase 3 trial S0427 evaluating combination chemotherapy and radiotherapy for stage III/IV cancer of the oropharynx; the study has been termi…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers [Phase 1, Phase 2]
This clinical trial update describes a pilot phase 1/2 study evaluating ALTENS to improve dysphagia caused by IMRT in head and neck cancer p…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer
A completed clinical trial from MD Anderson Cancer Center examining body image functioning among patients surgically treated for head and ne…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial S0329 evaluating gemcitabine and paclitaxel in patients with persistent, recurrent, or metastatic head and neck cancer has com…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Clinical Evaluation of the New Hypoxia Imaging Agent HX4 [Phase 1, Phase 2]
This document reports the completion of Phase 1 and Phase 2 clinical evaluation of the hypoxia imaging agent HX4 in cancers including head a…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer [Phase 3]
A Phase 3 trial evaluating radiation therapy with or without epoetin alfa in patients with head and neck cancer has been terminated. The stu…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck [Phase 2]
This document notes a Phase 2 trial of gemcitabine for recurrent or metastatic adenoid cystic carcinoma of the head and neck, with the study…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: NGR-TNF in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update showing completion of a study evaluating NGR-TNF in patients with advanced solid tumors, including colorectal cancer, h…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx [Phase 2]
Phase 2 trial evaluating chemotherapy plus radiation with or without amifostine for locally advanced nasopharyngeal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: INEC Study: Immuno-modulating Enteral Nutrition in Cancer [Phase 4]
Phase 4 trial of immuno-modulating enteral nutrition in cancer has completed, including patients with malnutrition and cancers of the esopha…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer
This completed clinical trial evaluated whether gene expression profiles can predict survival in patients with head and neck cancer. The stu…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Family Quality of Life Among Families With a Member Who is a Cancer Patient
A completed ClinicalTrials.gov study from Vanderbilt-Ingram Cancer Center assessing family quality of life in households with a member who h…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer
The trial update notes completion of a Vanderbilt-Ingram Cancer Center study examining pain and symptom burden in patients with newly diagno…
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema [NA]
A clinical trial evaluating complete decongestive therapy for head and neck lymphedema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy [NA]
A clinical trial evaluating reflux disease in head and neck cancer patients undergoing radiation therapy was withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Phase II Study of TAS-106 to Treat Head and Neck Cancer [Phase 2]
Phase II study of TAS-106 for head and neck cancer was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
This clinical trial update reports results from the Phase 2 S0618 E7389 study of eribulin mesylate in patients with metastatic or recurrent …
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
This completed clinical trial update compares sexual behavior between oropharyngeal cancer patients and other head and neck cancer patients,…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.